Aro Biotherapeutics Announces Leadership Transition: Purnanand Sarma, Ph.D., Appointed as CEO

Philadelphia, February 11, 2025 (Business Wire) -- Aro Biotherapeutics is undergoing a leadership transition, with co-founder Susan Dillon stepping down as CEO while remaining chair of the Board and an advisor. Purnanand Sarma has been appointed as the new CEO, bringing extensive industry experience to the role. The move underscores Aro’s focus on maintaining strategic momentum while leveraging strong leadership.

Read full article here.